Clinical trial · Observational
Retrospective, Non-interventional Study of Depo-Eligard®.
Monitoring Tolerance, Safety and Acceptance of Depo-Eligard® in an Open Label, Retrospective, Non-interventional Clinical Trial
NCT00811876CI-TRIAL-00003056OCTcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Study will evaluate the real-world effectiveness of Depo-Eligard® after six months of treatment
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Data Collection on Depo-Eligard exposure | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Tolerance, Safety (Adverse drug reactions, overall evaluation of safety and tolerability) and Acceptance of Depo-Eligard®
- timeFrame
- After at least 6 months treatment with Depo-Eligard
Secondary outcomes (3)
- measure
- Measurement of PSA and testosterone levels if available
- timeFrame
- After at least 6 months treatment with Depo-Eligard
- measure
- Overall evaluation of efficacy
- timeFrame
- After a least 6 months treatment with Depo-Eligard
- measure
- Overall patient assessment of treatment benefit
- timeFrame
- After at least 6 months treatment with Depo-Eligard
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients having been prescribed Depo-Eligard® in accordance with the terms of the marketing authorization * Patients on treatment with Depo-Eligard® for at least six months * Written consent has been obtained
References
Publications (0)
Data not yet available
No reference posted for this study.